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Polychlorinated biphenyls (PCBs) and other
organochlorines that are emitted into the
environment at middle and lower latitudes
reach the Arctic via long-range atmospheric
and oceanic transport (Barrie et al. 1992;
Macdonald et al. 2000). High lipophilicity
and poor biodegradability lead to their bio-
concentration in fatty tissues of organisms.
Biomagnification also occurs through the
Arctic aquatic food chain, resulting in rela-
tively high levels of PCBs being found in sea
mammal species (Muir et al. 1992; Norstrom
and Muir 1994).
For cultural and economic reasons, the
Inuit from Nunavik (Arctic Québec, Canada)
rely heavily on marine foods for their subsis-
tence (Dewailly et al. 1993). A population
study conducted in 1989–1990 revealed that
because of their heavy consumption of sea
mammal fat (in particular, ringed seal and
beluga), Inuit women display a mean total
PCB concentration in breast milk exceeding
that of southern Québec women by a factor
of 7 (Dewailly et al. 1993).
Prospective longitudinal studies conducted
in The Netherlands and in Michigan, North
Carolina, and Oswego, New York (USA), have
found adverse developmental effects from birth
to childhood in relation to prenatal exposure
to PCBs and other organochlorines from envi-
ronmental sources. Associations between PCB
exposure and decreased newborn behavioral
function (e.g., reflexes, tonicity, and activity
levels) were reported in three of the four stud-
ies (Huisman et al. 1995a; Rogan et al. 1986a;
Stewart et al. 2000). Adverse neurologic effects
lasting up to 18 months of age were found in
the Dutch study (Huisman et al. 1995b). Both
the Michigan and Dutch studies reported that
prenatal PCB exposure was associated with
lower birth weight and slower growth rate (Fein
et al. 1984; Jacobson et al. 1990a; Patandin
et al. 1998). In the Michigan and Oswego
cohorts, prenatal PCB exposure was associated
with poorer visual recognition memory during
infancy (Darvill et al. 2000; Jacobson et al.
1985, 1990b, 1992). Deﬁcits in psychomotor
development lasting up to 24 months were
noted in the most highly exposed children of
the North Carolina cohort (Gladen et al.
1988; Rogan and Gladen 1991). Prenatal PCB
exposure was linked to poorer intellectual
function at 4 and 11 years in the children of
the Michigan cohort (Jacobson et al. 1990b;
Jacobson and Jacobson 1996) and at 42
months in the Dutch cohort (Patandin et al.
1999). Recently, results from a fifth cohort,
from Düsseldorf, indicated that prenatal expo-
sure to PCBs was negatively related to men-
tal/motor development at 30 and 42 months.
These effects were considered “PCB matrix”
dependent because associations were noted
with breast milk levels and not with cord
blood concentrations. In addition, the authors
reported a negative effect of postnatal PCB
exposure on an intelligence test performed at
42 months (Walkowiak et al. 2001).
The latter results raise two controversial
issues that researchers in this ﬁeld have argued
over for years. First, because associations with
adverse developmental effects have been
observed with PCB levels in some biologic
media but not others, uncertainty has emerged
regarding the most appropriate index of prena-
tal exposure to PCBs (Ribas-Fitó et al. 2001).
Hence, there is a need to investigate the validity
of various biologic measures of prenatal expo-
sure to PCBs. Second, developmental deﬁcits
have been most consistently linked to prenatal,
not postnatal, exposure (Jacobson and Jacobson
2001). However, assessing postnatal exposure
to PCBs in infants is problematic because of
the difﬁculty in obtaining a sufﬁcient volume
of plasma to perform PCB analysis. To cir-
cumvent this problem, some researchers have
estimated postnatal exposure to PCBs by
multiplying the concentration of PCBs in
breast milk by the breast-feeding duration
(Koopman-Esseboom et al. 1996; Walkowiak
et al. 2001). More elaborate models have been
proposed to predict PCB body burden in 42-
month-old children (Lanting et al. 1998;
Patandin et al. 1997), but these may not be
applicable to infants during the ﬁrst year of life.
In 1995, we initiated The Inuit Cohort
Study to investigate adverse neurodevelop-
mental effects induced by developmental
PCB exposure in Inuit infants from Nunavik.
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Polychlorinated biphenyls (PCBs) are food-chain contaminants that have been shown to induce
adverse developmental effects in humans. In the course of an epidemiologic study established to
investigate neurodevelopmental deﬁcits induced by environmental PCB exposure in the Inuit pop-
ulation of northern Québec (Nunavik, Canada), we compared three biomarkers of prenatal expo-
sure and models to predict PCB plasma concentration at 6 months postpartum. Concentrations of
14 PCB congeners were measured by high-resolution gas chromatography with electron capture
detection in lipids extracted from maternal plasma, cord plasma, breast milk (collected at ~1
month postpartum), and 6-month-old infant plasma samples. Similar congener profiles were
observed in all biologic samples, and PCB-153, the most abundant and persistent PCB congener,
was strongly correlated with other frequently detected PCB congeners in all biologic media. When
expressed on a lipid basis, maternal plasma, cord plasma, and milk concentrations of this congener
were strongly intercorrelated, indicating that PCB concentration in any of these biologic media is
a good indicator of prenatal exposure to PCBs. A multivariate model that included maternal PCB-
153 plasma lipid concentration, breast-feeding duration, and the sum of two skin-fold thicknesses
(an index of infant body fat mass) explained 72% of PCB-153 plasma concentration variance at
6 months postpartum (p < 0.001). By contrast, based on the product of breast-feeding duration
times the concentration of PCBs in plasma lipids, which was used as an index of postnatal PCB
exposure in several studies, only 36% of infant plasma concentration was explained. Key words:
breast-feeding, Canada, infant, Inuit, lactational exposure, polychlorinated biphenyls, prenatal
exposure. Environ Health Perspect 111:1253–1258 (2003). doi:10.1289/ehp.6054 available via
http://dx.doi.org/ [Online 2 April 2003]
Children’s Health | ArticleThis article is the third in a series reporting
results from this epidemiologic study. The ﬁrst
article described determinants of PCBs and
methylmercury exposure in Inuit women par-
ticipating in the study (Muckle et al. 2001a).
Fish and seal meat consumption was associ-
ated with increased hair Hg concentrations.
Traditional food intake during pregnancy was
unrelated to PCB body burden, which is more
a function of lifetime consumption. The second
article presented data on the magnitude of pre-
natal exposure of Inuit mothers and their new-
borns to these contaminants and to selected
nutrients (Muckle et al. 2001b). To assess pre-
natal exposure in this study, we measured
concentrations of 14 PCB congeners and 11
chlorinated pesticides in maternal plasma,
umbilical cord plasma, and breast milk samples.
Postnatal exposure was evaluated by quantify-
ing PCBs in plasma samples from 6-month-old
infants. Here we report on PCB proﬁles in the
various biologic samples and the correlations
between PCB levels among biologic media.
Factors associated with PCB plasma lipid
concentrations in 6-month-old infants are
also presented. Finally, we compare the predic-
tive value of various models to estimate PCB
plasma concentrations in Inuit infants during
the ﬁrst year of life.
Materials and Methods
Population. Nunavik is a region of Québec
located north of the 55 parallel, where 7,660
Inuit reside in 14 villages scattered along 2,000
km of the Hudson Bay and Ungava Bay shore-
lines (Figure 1). Starting in November 1995,
all pregnant women from three communities
(Puvirnituq, Inukjuaq, Kuujjuaraapik) were
invited to participate in a longitudinal study of
determinants of health and development dur-
ing infancy. A research assistant explained the
purpose of the study, and women were enrolled
after signing an informed consent form. The
study protocol was reviewed and approved by
the Nunavik Nutrition and Health Committee
and by ethic committees of Université Laval and
Wayne State University. As of November 1998,
141 mothers had completed the prenatal and
postnatal interviews (84% participation rate),
and PCB plasma concentrations were available
from 128 of them. Data on PCB plasma con-
centration were available for 90 infants who
had reached the age of 6 months.
Sociodemographic and physical characteris-
tics of the mother were obtained during one
prenatal and two postnatal interviews (1 month
and 12 months postpartum). Infant body
weight, height, and skin-fold thickness (triceps
and subscapular) were measured during an
additional visit at the local clinic when infants
were approximately 6 months old (median =
210 days postpartum).
PCB analyses in biologic samples. Maternal
blood samples (12.5 mL) were collected for the
most part at delivery (median = 2 days postpar-
tum). Cord blood samples (30 mL) were col-
lected after the umbilical cord was severed.
Infant blood samples (5 mL) were drawn when
infants were approximately 6 months old
(median = 206 days postpartum). Blood sam-
ples were collected in vials containing ethylene-
diamine tetraacetate and centrifuged (10 min,
5,000 rpm), and the plasma was transferred in
glass vials prewashed with hexane. Plasma sam-
ples were stored frozen at –80°C until time of
analysis. A 2-mL aliquot of plasma was first
extracted with a mixture of ammonium sul-
fate/ethanol/hexane (1:1:3), and the lipid
extract was concentrated and cleaned up on
Florisil columns. Fourteen PCB congeners
(International Union for Pure and Applied
Chemistry no. 28, 52, 99, 101, 105, 118,
128, 138, 153, 156, 170, 180, 183, 187)
(Ballschmitter and Zell 1980) were quantiﬁed in
the eluate using a HP-5890 series II gas chro-
matograph (Hewlett-Packard, Palo Alto, CA,
USA) equipped with dual-capillary columns
(HP Ultra I and Ultra II; Hewlett-Packard) and
dual Ni-63 electron-capture detectors (Hewlett-
Packard). Peaks were identiﬁed by their relative
retention times obtained on the two columns,
using a computer program developed in-house.
Quantiﬁcation was mainly performed on the
Ultra-1 column. Quality control procedures
for PCB analyses were described previously
(Rhainds et al. 1999). The limit of detection of
the method [mean of blank + (3× standard
deviation of blank)] was about 0.02 µg/L for
each PCB congener (0.02–0.1 µg/L in the case
of infant blood samples). Percent recoveries
varied from 92 to 98% for individual con-
geners. Coefﬁcients of variation (n = 20, differ-
ent days) ranged from 2.1 to 7.5% and biases
from –10.9 to 3.8%. The laboratory of
the Institut National de Santé Publique
du Québec is accredited by the Canadian
Association for Environmental Analytical
Laboratories.
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Figure 1. Location of Nunavik communities (Arctic Québec, Canada).Breast milk samples (25 mL) were col-
lected by manual expression in polycarbonate
vials approximately 1 month after delivery
(median = 35 days postpartum). Milk samples
were stored frozen at –20°C until time of analy-
sis. PCB congeners were extracted from milk
using a mixture of acetone/hexane, followed by
hexane alone. Combined organic phases were
washed with deionized water, concentrated,
and puriﬁed on activated Florisil columns. A
mixture of dichloromethane/hexane was used
to elute the compounds, which were separated
and quantified by high-resolution gas chro-
matography as described above. Detection lim-
its vary from 0.08 to 0.16 µg/L for the various
PCBs. Two certiﬁed milk reference materials
(CRM 188 and 450; Community Bureau of
Reference, Brussels, Belgium) were used to
assess precision and accuracy of the results.
Coefficients of variation varied from 10 to
20%, and relative biases 5 to 15%, depending
on the speciﬁc congener.
Lipid analyses. Because PCBs distribute
mainly in body fat, concentrations in plasma or
milk samples were reported in micrograms per
kilogram of lipids. Total cholesterol, free choles-
terol, and triglycerides were measured in plasma
samples by standard enzymatic procedures,
whereas phospholipids were determined accord-
ing to the enzymatic method of Takayama et al.
(1977) using a commercial kit (Wako Pure
Chemical Industries, Richmond, VA, USA).
The concentration of total plasma lipids was
estimated according to the formula developed
by Phillips et al. (1989). An aliquot of the milk
fat extract was weighed in order to determine
the concentration of lipids in milk samples.
Statistical analysis. PCB concentrations in
biologic samples followed a log-normal distrib-
ution. Hence, geometric means and conﬁdence
intervals are presented in descriptive statistics,
and statistical analyses were performed using
log-transformed values (loge). Whenever chem-
ical analysis yielded a “not detected” result, a
value equal to half the limit of detection of the
analytical method was entered in the database.
Pearson correlation coefficients were used to
test a) intercorrelations among concentrations
of various PCB congeners within each biologic
medium and b) intercorrelations among PCB-
153 concentrations in the four biologic media.
An analysis of variance followed by the
Bonferroni post hoc test was used to assess the
impact of exclusive breast-feeding duration
(never, ≤ 3 months, > 3 months) on infant
plasma lipid PCB concentrations. Maternal
and infant characteristics associated with infant
plasma PCB concentrations were identified
using stepwise multiple regression analyses.
The following variables were included in the
model: maternal plasma PCB concentration (log
micrograms per kilogram lipids), maternal
weight before pregnancy (kilograms), maternal
height (centimeters), maternal age at birth
(years), parity, the average number of cigarettes
smoked per day during pregnancy, gestational
age (weeks), exclusive breast-feeding duration
(days), mixed breast- and bottle-feeding dura-
tion (days), infant’s weight (kilograms), infant’s
height (centimeters), infant’s body mass index
(kilograms per square meter), and the sum of
skin-fold thicknesses (millimeters). We included
in the ﬁnal model only the independent vari-
ables identiﬁed as statistically signiﬁcant pre-
dictors by the stepwise procedure. All statistical
analyses were performed using the SPSS for
Windows statistical package (version 8.0; SPSS
Inc., Chicago, IL, USA).
Results
Characteristics of Inuit women enrolled in the
present study and their offspring are presented
in Table 1. Fourteen percent of participants
were younger than 18 years, and 4.7% were
older than 35 years. Twenty-two percent of
women were primiparous, and 33% already had
three or more children. All but nine women
(5.5%) smoked during pregnancy. Few women
did not breast-feed their infants (13%); 32% of
infants were exclusively breast-fed for 3 months
or less, whereas 55% were exclusively breast-fed
for more than 3 months. Two newborns (2%)
weighed less than 2,500 g at birth.
PCB congeners 99, 118, 138, 153, 180,
and 187 were detected in more than 70%
of maternal and infant biologic samples.
Congener profiles were remarkably similar
among the different biologic samples (Figure
2). The most abundant PCB congener in all
biologic samples was PCB-153, representing
close to 40% of total PCB concentration
defined as the sum of the 6 PCB congeners
mentioned above. Congeners 138, 180, 99,
187, and 118 followed in decreasing order,
averaging, respectively, 23, 15, 8, 8, and 6% of
the total PCB concentration in each of the bio-
logic media. Furthermore, PCB-153 concen-
tration was strongly correlated to those of other
frequently detected PCB congeners whether in
plasma (maternal, neonate, infant) or breast
milk (all Pearson’s r > 0.84; p < 0.001).
Further statistical analyses were limited to
PCB-153 because its concentration is a good
indicator of all persistent PCBs measured in
the present study.
Table 2 presents concentrations of
PCB-153 in all four biologic media. The high-
est concentrations were found in breast milk,
followed by maternal plasma, cord plasma, and
infant plasma. Mean cord plasma to breast milk
concentration ratio was 0.63 (range, 0.22–1.71;
n = 55), mean cord plasma to maternal plasma
was 0.81 (range, 0.30–2.54; n = 79), and mean
maternal plasma to breast milk was 0.77 (range,
0.29–1.37; n = 84). We noted very strong cor-
relations among concentrations of PCB-153 in
maternal and cord plasma and maternal milk
samples, as indicated in Table 3 (all Pearson’s
r > 0.92; p < 0.001). In contrast, PCB-153
plasma concentrations in 6-month-old infants
Children’s Health | PCB exposure in Inuit infants
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Table 1. Characteristics of participants.
Characteristics No. Mean ± SD Range
Maternal
Age (years) 128 24.4 ± 5.7 14.1–40.7
Education (years) 128 8.7 ± 1.6 6–13
Language of interview (% Inuktitut) 128 20.0 —
Weight before pregnancy (kg) 89 59.8 ± 11.3 40.7–94.5
Parity 128 2.0 ± 1.8 0–9
Smoker (%) 128 94.5 —
Cigarettes/daya 121 10.5 ± 5.6 1–25
Breast-feeding (%) 94 87.2 —
Exclusive breast-feeding duration (days) 94 103.2 ± 82.5 0–292
Mixed breast- and bottle-feeding duration (days) 92 38.1 ± 64.7 0–239
Neonate
Weight (kg) 108 3.5 ± 0.5 1.9–4.8
Gestational age (weeks) 108 38.8 ± 1.9 32–42
Infant (6 months old)
Weight (kg) 80 9.6 ± 1.2 7.3–12.9
Height (cm) 83 67.6 ± 3.0 56.4–74.5
Body mass index (kg/m2)8 0 20.1 ± 2.3 16.1–26.8
Subscapular skin-fold thickness (mm) 83 12.4 ± 3.3 6.0–22.0
Triceps skin-fold thickness (mm) 84 13.5 ± 3.3 5.5–22.0
Sum of skin-fold thicknesses (mm) 83 25.9 ± 6.0 11.5–44.0
aAmong smokers.
Figure 2. Percentage of total PCB concentration for
six congeners detected in more than 70% of mater-
nal and infant plasma samples. Each bar repre-
sents the mean ± SD. Only samples containing
detectable concentrations of all six congeners
were included in calculations.
Maternal plasma (n = 127)
Maternal milk (n = 84)
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PCB 99 PCB 118 PCB 138 PCB 153 PCB 180 PCB 187were weakly correlated to maternal plasma,
cord plasma, or breast milk concentrations (r =
0.29 – 0.42; p < 0.01).
We explored the relation between breast-
feeding duration and plasma PCB levels in 
6-month-old infants by stratifying in three cate-
gories: never breast-fed, exclusive breast-feeding
for 3 months or less, and exclusive breast-feed-
ing for more than 3 months (Table 4). Mean
PCB plasma lipid concentration in infants who
were breast-fed for more than 3 months was
4.3-fold greater and 6.6-fold greater, respec-
tively (p < 0.001), than those of infants who
were breast-fed for 3 months or less and never
breast-fed infants.
Initially, we performed a stepwise regression
analysis to identify, among several maternal
and infant characteristics (see “Materials and
Methods,” Statistical analysis), those associated
with plasma PCB concentration at 6 months of
age. Maternal plasma lipid PCB-153 concen-
tration, the duration of exclusive breast-feed-
ing, the duration of mixed (breast + bottle)
feeding, and the sum of skin-fold thicknesses
were the only statistically signiﬁcant predictors
of infant plasma PCB-153 levels. In the ﬁnal
model shown in Table 5 (R2 = 0.72; p < 0.001;
n = 75), the duration of exclusive breast-feeding,
the duration of mixed feeding, and maternal
PCB-153 plasma lipid concentration were all
positively associated with infant’s PCB-153
plasma lipid concentration (p < 0.001), whereas
the sum of two skin-fold thicknesses, a surrogate
for infant body fat mass, was negatively associ-
ated with the dependent variable (p < 0.01).
Substituting body weight for the sum of skin-
fold thicknesses yielded a similar but slightly
weaker model (R2 = 0.69). Maternal plasma
lipid PCB-153 concentration was used in
regression analyses to index maternal body bur-
den because it was very highly correlated with
milk PCB-153 concentration and available for
more infants.
Various regression models to predict PCB
plasma lipid concentration in Inuit infants are
presented in Table 6. Almost identical models
were obtained using total PCBs concentra-
tions instead of PCB-153 concentrations
(data not shown). As expected, the concentra-
tion of PCB-153 in maternal plasma lipids
and the breast-feeding duration considered
individually (R2 = 0.08 and 0.53, respec-
tively) did not predict infant PCB concentra-
tion as well as when both factors were
included in the model (R2 = 0.66). Adding
the sum of skin-fold thicknesses to the later
model did not improve its predictive value
(data not shown). A model that incorporates
the product of total breast-feeding (exclusive
and mixed) duration multiplied by PCB-153
concentration in maternal plasma lipids had
only a weak predictive value (36% of the vari-
ance explained). Clearly, the multivariate
model composed of the independent variables
presented in Table 5 provides the strongest
prediction; it explained 72% of the variance
in infant PCB plasma concentration.
Discussion
Our study aimed to compare different bio-
markers of prenatal PCB exposure and models
to predict PCB plasma lipid concentration in
6-month-old infants, using data from the Inuit
Cohort Study, a large epidemiologic study tak-
ing place in Nunavik that investigates the role
of pre- and postnatal exposure to PCBs and
heavy metals on various developmental end
points during the ﬁrst year of life (Muckle et
al. 2001a, 2001b). When expressed on a lipid
basis, concentrations of PCB-153 in umbilical
cord plasma, maternal plasma, and breast milk
were all highly intercorrelated, indicating that
any of these biologic media can be used to
assess prenatal PCB exposure. We also found
that infant PCB plasma concentration was pre-
dicted best by a model that contained measures
of maternal PCB concentration in body lipids,
breast-feeding duration, and infant fat mass.
Previous studies have reported maternal
concentrations of PCBs in milk or plasma
(serum) samples and concentrations in umbili-
cal cord plasma (serum) samples in various
populations (Jacobson et al. 1984; Koopman-
Esseboom 1994; Rogan et al. 1986b; Skaare et
al. 1988). However, failure in most of these
studies to report concentrations of these
lipophilic compounds on a lipid basis made it
difficult to assess properly the relationships
between PCB concentrations in these biologic
samples. For example, Skaare et al. (1988)
reported a mean PCB concentration of 10 µg/kg
wet weight in 20 maternal serum samples,
whereas the mean concentration in correspond-
ing cord plasma samples was only 3 µg/kg (12 of
20 cord plasma samples had detectable levels);
the authors concluded that their results were
consistent with the notion that the placenta may
function as a partial barrier protecting the fetus
from transplacental exposure. Dekoning and
Karmaus (2000) recently reviewed the litera-
ture on this subject and calculated cord-to-
maternal blood ratios ranging from 0.59 to 1.1
when data from four studies were expressed on
a lipid basis. In our study, cord plasma PCB
concentrations expressed on a lipid basis were
on average 81% of those in maternal plasma. A
similar ratio (0.87) was obtained recently
among Inuit women and their neonates from
Greenland when total PCB levels in plasma
were expressed on a lipid basis (Bjerregaard and
Hansen 2000). Furthermore, in our study very
high correlation coefficients were noted
between maternal plasma, breast milk, and
cord plasma levels (Table 3), and similar con-
gener profiles were noted in maternal and
neonates samples (Figure 2). Taken together,
these results indicate that the placenta does not
constitute a barrier to the transfer of major
PCB congeners from the mother to the fetus
and that these compounds are transported by
passive diffusion to all body lipids. It follows
that concentrations of PCBs in maternal
plasma, milk, and umbilical cord plasma can
all be used as surrogates of prenatal exposure to
PCBs. Therefore, associations reported previ-
ously between neurodevelopmental outcomes
and prenatal PCB exposure that appeared
dependent on the “PCB matrix” (i.e., associa-
tions observed with PCB concentrations in one
biologic sample but not in others) are likely
due to analytical problems, as suggested by
Walkowiak et al. (2001). These problems may
arise from the lower concentration of lipids in
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Table 2. PCB-153 concentration (µg/kg lipids) in biologic samples from Inuit mothers and their offspring at
birth and 6 months of age.
Biologic sample No. Percent detected Geometric mean 95% CI Range
Maternal plasma 128 100.0 105.1 92.5–119.5 18.9–709.0
Maternal milk 84 100.0 129.9 112.9–149.5 40.5–727.9
Cord plasma 79 100.0 82.5 69.1–98.5 13.4–550.9
Infant plasma 90 96.7 75.1 58.1–97.1 3.6–888.9
95% CI, 95% conﬁdence interval.
Table 3. Correlations among PCB-153 concentrations in biologic samples (log-transformed values).
6-Month-old
Maternal plasma Milk Cord plasma infant plasma
Maternal plasma 1.00 (128)a 0.95** (84) 0.94** (79) 0.29* (90)
Milk 1.00 (84) 0.92** (55) 0.42** (66)
Cord plasma 1.00 (79) 0.33* (57)
6-Month-old infant plasma 1.00 (90)
aValues are Pearson’s r (n). *p ≤ 0.01; **p ≤ 0.001.
Table 4. Concentration of PCB-153 in plasma lipids
of 6-month-old Inuit infants according to duration
of exclusive breast-feeding.
Breast-feeding No. GM 95% CI F-valuea
Never 14 23.1 12.0–44.7
≤ 3 Months 26 36.0 24.0–54.1
> 3 Months 50 153.0b* 121.4–192.9 34.2*
Abbreviations: 95% CI, 95% conﬁdence interval; GM, geo-
metric mean.
aF-value for a one-way analysis of variance on log-trans-
formed values. bMean value significantly different from
those of the other groups (Bonferroni post hoc test). *p <
0.001.umbilical cord plasma than in maternal plasma
(2.8 g/L vs. 7.9 g/L in the present study),
which makes it more difﬁcult to measure PCBs
and other lipophilic compounds reliably in the
former biologic medium.
To our knowledge, our study is the ﬁrst to
investigate factors influencing plasma PCB
concentrations in infants during the ﬁrst year
of life. The major importance of breast-feeding
as a determinant of postnatal PCB exposure in
infants was demonstrated by stratifying accord-
ing to the breast-feeding duration. We observed
that infants who were breast-fed for more than
3 months displayed a mean plasma PCB con-
centration 6.6-fold higher than that of bottle-
fed infants (Table 4). Breast-feeding during
3 months or less increased the mean PCB con-
centration by only 56% compared with the
group never breast-fed. Lanting et al. (1998)
reported a mean PCB concentration 4.5 times
higher in 42-month-old Dutch children breast-
fed for at least 6 weeks compared with those
never breast-fed. In Dutch children of similar
age, Patandin et al. (1997) reported a mean
PCB plasma concentration 3-fold higher in the
breast-fed group than in the bottle-fed group.
In school-age children (7–10 years old) from
Germany, exclusive breast-feeding during more
than 3 months was associated with a doubling
of PCB plasma concentrations (Karmaus et al.
2001). Hence, exposure to these lipophilic
compounds through breast-feeding has a major
and long-lasting influence on the offspring
body burden. Using a toxicokinetic model that
takes into account exposure, the diluting effect
of body growth, and elimination processes, we
have predicted that the inﬂuence of breast-feed-
ing on the body burden of persistent organo-
chlorines would last until adulthood in the
Inuit population (Ayotte et al. 1996).
A multiple linear regression model that
included as statistically signiﬁcant predictors the
exclusive breast-feeding duration, PCB concen-
tration in maternal plasma, mixed (breast and
bottle) feeding duration, and the sum of two
skin-fold thicknesses explained 72% of plasma
lipid PCB concentration in 6-month-old Inuit
infants (Table 5). Although no other model was
elaborated speciﬁcally for infants, others have
looked at determinants of PCB plasma levels in
children. Jacobson et al. (1989) studied determi-
nants to PCB plasma concentration in 4-year-
old Michigan children and found that maternal
PCB milk level and breast-feeding duration
jointly explained 60% of the variance. Lanting
et al. (1998) presented a nonlinear model that
explained 75% of the variance in children’s
levels and included as predictors breast-feeding
duration (exclusive), feeding mode (breast or
formula), and concentrations of PCBs in cord
plasma and in breast milk. Patandin et al.
(1997) presented separate models for breast-fed
and bottle-fed infants. The formula-fed group
model explained 36% of the variance and
included as predictors maternal plasma levels,
maternal age, the weight of the child, and its
dietary PCB exposure. The breast-fed group
model explained 63% of the variance and con-
tained the following predictors: the duration of
breast-feeding, breast milk PCB concentration,
maternal plasma PCB concentration, maternal
age, the weight of the child, and dietary intake
of PCBs. However, only the duration of
breast-feeding, breast milk PCB concentration,
and the child’s weight showed statistically sig-
nificant associations with the child’s plasma
lipid concentration, similar to the model pre-
sented here for 6-month-old infants.
Throughout this study, we made the
implicit assumption that the concentration of
PCBs in infant body lipids is the most appro-
priate exposure metric to use in studying the
relation of postnatal PCB exposure to develop-
mental outcomes. Because PCBs are lipophilic
and stored mainly in body fat, the higher the
body fat mass, the greater the volume of distri-
bution and the lower the plasma lipid PCB
concentrations. In our model, the sum of two
skin-fold thicknesses measured on the infants
(triceps and subscapular), a marker of body fat
mass, showed a negative association with PCB
concentration in plasma lipids. Associations of
both maternal plasma lipid PCB concentration
and breast-feeding duration to infant plasma
lipid PCB concentration become stronger when
infant body fat mass is included in the model.
A statistically signiﬁcant negative but slightly
weaker association was also noted when the
infant body weight was entered in the model
instead of the sum of skin-fold thicknesses.
Skin-fold thicknesses are likely a better indica-
tor of infant body fat mass than is body weight.
In view of the particular source of exposure
to PCBs in the Inuit population (sea mammal
fat consumption), one might question the
degree to which our results are applicable to
other populations environmentally exposed to
these compounds. Longnecker et al. (2003)
reviewed PCB exposure levels from 10 studies
of PCB and neurodevelopment, including
ours; the authors noted that besides PCB-153,
which was the major congener present in
maternal biologic samples from nearly all stud-
ies, congeners 118, 138, and 180 were also
major congeners. Although similarities do exist
among studies, the ratio of median PCB-118
concentration to median PCB-153 concentra-
tion was the lowest in the Inuit population
(0.14), compared with values ranging from
0.18 to 0.87 in the other populations. These
results suggest that some differences in PCB
congener profiles exist across populations.
Notwithstanding these differences, it seems rea-
sonable to rely on a major congener such as
PCB-153, which is quantiﬁed in biologic sam-
ples with relative ease, possesses a long biologic
half-life, and is strongly correlated to other con-
geners, to assess PCB exposure within a given
population.
The model developed here to predict post-
natal PCB exposure (plasma lipid concentra-
tions at 6 months of age) should be applicable
to other populations environmentally exposed
to PCBs. Indeed, there is no reason to believe
that the factors associated with PCB plasma
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Table 5. Multiple linear regression analysis of plasma lipid PCB-153 concentration in 6-month-old Inuit
infants (n = 75).
Pearson’s r Standardized β Model R2
Maternal plasma PCB-153 (log µg/kg) 0.29* 0.36**
Exclusive breast-feeding duration (days) 0.68** 0.79**
Mixed breast- and bottle-feeding duration (days) 0.17 0.37**
Sum of skin-fold thicknesses (mm) –0.07 –0.20* 0.72**
*p < 0.01; **p < 0.001.
Table 6. Models predicting PCB-153 concentrations (log value µg/kg lipids) in 6-month-old infant plasma samples.
Predictors Equation R2
Maternal PCB-153 in plasma (n = 90) 2.126 + 0.467 × lnPCB-153maternal plasma 0.08*
Exclusive breast-feeding duration (n = 87) 3.262 + 1.015E-02 × exclusive breast-feeding duration (days) 0.47**
Total breast-feeding duration (n = 85) 2.926 + 9.645E-03 × total breast-feeding duration (days) 0.53**
Total breast-feeding duration × maternal
PCB plasma concentration (n = 85) 3.745 + 2.873E-05 × [PCB-153maternal plasma × total breast-feeding duration] (µg/kg lipids × days) 0.36**
Total breast-feeding duration and maternal
PCB plasma concentration (n = 85) 6.017E-02 + 9.961E-03 × total breast-feeding duration (days) + 0.603 × lnPCB-153maternal plasma 0.66**
Multivariate model (n = 75) 1.137 + 0.576 × lnPCB-153maternal plasma + 1.171E-02 × exclusive breast-feeding duration (days)
+ 6.901E-03 × mixed breast-feeding duration (days) – 6.73E-02 × sum of skin-fold thicknesses (mm) 0.72**
*p < 0.01; **p < 0.001.levels in Inuit infants at 6 months of age—
breast-feeding duration, maternal PCB plasma
levels, and infant body fat mass (as represented
by skin-fold thickness measurements)—would
not apply to infants from other populations.
The ingestion of solid foods such as beluga
whale skin and fat that are highly contami-
nated by PCBs could theoretically contribute
to postnatal PCB exposure in Inuit infants.
However, these traditional food items are
rarely introduced in the diet at such an early
age in this population (2% of mothers men-
tioned giving sea mammal fat or skin to their
infant in our study).
Our model requires the knowledge of
breast-feeding duration and an index of the
body fat mass, in addition to a measure of
maternal PCB body burden. However, it pro-
vides much more reliable predictions of the
infant PCB plasma lipid concentration than
does the simple product of PCB concentration
in maternal lipids times the breast-feeding dura-
tion, which has been used by some researchers
in previous developmental studies (Koopman-
Esseboom et al. 1996; Walkowiak et al. 2001).
Clearly, the possible involvement of postnatal
PCB exposure on child development must be
assessed using more appropriate models, such as
the one presented in this article.
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